ArticlePloS one2014

An EGFR/HER2-Bispecific and enediyne-energized fusion protein shows high efficacy against esophageal cancer.

Xiao-Fang Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.